| CTRI Number |
CTRI/2024/03/064346 [Registered on: 18/03/2024] Trial Registered Prospectively |
| Last Modified On: |
18/09/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Biological Behavioral Other (Specify) [health edcuation] |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
Telemedicine effectiveness in blood sugar control and lifestyle modification. |
|
Scientific Title of Study
|
Effectiveness of Telemedicine and Electronic Call Reminder and health Education (TECARE trial) for Diabetes : A Randomized Control Trial |
| Trial Acronym |
TECARE |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Vinoth Gnana Chellaiyan Devanbu |
| Designation |
Professor |
| Affiliation |
Chettinad Hospital and Research Institute |
| Address |
Chettinad Hospital and research Institute
OMR Kelambakkam
Chennai
Chennai TAMIL NADU 603103 India |
| Phone |
09944894554 |
| Fax |
|
| Email |
drchellaiyan@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Vinoth Gnana Chellaiyan Devanbu |
| Designation |
Professor |
| Affiliation |
Chettinad Hospital and Research Institute |
| Address |
Chettinad Hospital and Research Institute
OMR Kelambakkam
Chennai
Chennai TAMIL NADU 603103 India |
| Phone |
09944894554 |
| Fax |
|
| Email |
drchellaiyan@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Vinoth Gnana Chellaiyan Devanbu |
| Designation |
Professor |
| Affiliation |
Chettinad Hospital and Research Institute |
| Address |
Chettinad Hospital and Research Institute
OMR Kelambakkam
Chennai
Chennai TAMIL NADU 603103 India |
| Phone |
09944894554 |
| Fax |
|
| Email |
drchellaiyan@gmail.com |
|
|
Source of Monetary or Material Support
|
| Indian Council of Medical Research
V. Ramalingaswami Bhawan, P.O. Box No. 4911. Ansari Nagar, New Delhi - 110029, India Ph: 91-11-26588895 |
|
|
Primary Sponsor
|
| Name |
ICMR |
| Address |
Indian Council of Medical Research. V. Ramalingaswami Bhawan, P.O. Box No. 4911. Ansari Nagar, New Delhi - 110029, |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Vinoth G Chellaiyan |
Chettinad Hospital and Research institute |
Room no.7, Department of Community Medicine, A- Block, Chettinad Hospital & Research Institute, CHettinad Health City,
OMR Kelambakkam
Chennai-603103 Chennai TAMIL NADU |
9944894554
drchellaiyan@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| CARE IHEC II |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: E089||Diabetes mellitus due to underlying condition without complications, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Regular follow up |
Regular visit the diabetic clinic at regular intervals of 3 months and consultation
|
| Intervention |
Telemedicine Support |
Integrated Voice Response System and teleconsulation
|
|
|
Inclusion Criteria
|
| Age From |
30.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
The inclusion criteria are as follows :
1. Age group between 30 to 65 years, both sexes.
2. Patients who have personal mobile phones
3. Patients who speak and understand either English/ Regional (Tamil) language
|
|
| ExclusionCriteria |
| Details |
1. Pregnant and lactating women
2. Patients who are involved in any wellness programs
3. Patients with history of heart diseases
4. Patients with any orthopedic conditions that restrict physical activity
5. Patients with hearing difficulties such as hard of hearing
6. Patients with difficulties in vision
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| The primary outcome measure of the study is decrease in HbA1c |
The primary outcome will be measured at baseline,6 months, 9 months and at 12 months. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| . The secondary outcomes are adherence to the drug and medication advice, adherence to dietary advice, and adherence to physical activity advice. |
at the end of 12th month |
|
|
Target Sample Size
|
Total Sample Size="200" Sample Size from India="200"
Final Enrollment numbers achieved (Total)= "200"
Final Enrollment numbers achieved (India)="200" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
01/04/2024 |
| Date of Study Completion (India) |
Date Missing |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
30/06/2024 |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Data are available indefinitely at (Link to be included NIL).
- For how long will this data be available start date provided 01-01-2025 and end date provided 01-06-2025?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Summary of Background Problem Statement : According to the International Diabetes Federation, the prevalence estimates of type 2 diabetes mellitus by 2040 will reach to 700 million from the current level of 463 million in 2019. Around three- fourths of this burden live in low and middle income countries including India.1-3 In India, the number of people with diabetes was 65 million with prevalence of 11.8% as per Ministry of Health and Family Welfare National Diabetes Survey report in 2019.4 With this high burden of disease in the country, it is very crucial in controlling the disease burden by continuous monitoring of disease and avoiding complication.5 However, the prevention and management of diabetes is largely influenced by individual behavior which can be achieved by extending the support beyond the clinic. This supportive role of patients by empowering individuals with information about the lifestyle and behaviors could be achieved by technology.6 Literature review Following table provides an overview of studies conducted across the world which utilized technology as intervention. Table 1 Literature review Author | Country | Study design | Study population | Intervention | Results | Ramachandran et al9 | India | Randomized controlled trial | Non diabetics 35-55 years | Mobile phone messages | 18% developed T2DM in the intervention group compared to 27% in the controls | Pfammatter et al10 | India | Cohort study | Non diabetics | Mobile phone messages | The intervention group reported an improvement in diabetes risk behaviors, specifically in fruit, vegetable, and fat consumption | Faridi et al11 | United states | Randomized controlled trial | Controlled diabetes population | Mobile phone messages | Improvement in HbA1c and self‑efficacy | Wong et al12 | China | Randomized controlled trial | Professional drivers who are pre-diabetics | Mobile phone messages | 6% developed T2DM in the intervention group compared to 16% in the control group | Bin Abbos et al13 | Saudi arabia | Non randomized trial | Diabetes patients | Mobile phone messages | The HbA1c decreased from 9.9% to 9.5%, | Present study | India | Randomized controlled trial | Diabetes patients | 1. Interactive voice response system 2. Tele consultation | Multiple Expected outcomes : I1.mprovement in HbA1c and other glycemic parameters 2.adherence to management practices 3.Cost effectiveness analysis |
Bold font represents uniqueness and highlights of the study Rationale of the study : During March 2020, to provide equitable access to healthcare in India, NITI Aayog, Government of India, has published the telemedicine guidelines for the practice in India. In India, telemedicine practice for control and management of chronic diseases such as diabetes could help in coverage of services to larger geographical area, given the higher prevalence of diabetes in our country.7,8 The prevalence of diabetes in India is very high at around 12%. The country has three fourth of its population living in rural areas. Equitable access to healthcare in addition to adequate monitoring is the need of the hour to control the diabetes burden of the country. This gap can be filled by telemedicine practice. Implementing telemedicine in control and monitoring could keep diabetes morbidity in control and avoid progression to complications of diabetes. The present study is an attempt to assess the impact of health education through technology on control of diabetes. Novelty / Innovation : 1.Government of India in March 2020, has approved the practice of telemedicine in India and published guidelines to be followed. An RMP may proceed with his/her professional judgment to provide health promotion such as health education and counseling, as well as management of diseases. With this guidelines in place, the present study would assess the impact of such telemedicine practice for diabetes control in India. 2.Previous studies done across the globe using technology utilized short messaging services or software application based intervention, had limitations such as literacy status and lower ability to use the functions of the software application. The present study is planned in such a way that lack of certain factors such as reading and other skills should not interfere with the delivery of health education to patients with diabetes. 3. The present study involves dual service delivery- Interactive voice response system and video tele consultation for patients in intervention arm. Hypothesis/ Research question 1. What is the impact of practice of telemedicine intervention on Diabetes control ? 2. How effective is the telemedicine practice in controlling the diabetes and maintaining adherence to diabetes management practices ? Study Objectives The objectives of the study are 1. To evaluate the effect of intervention on Diabetes control with anthropometric measures and biochemical parameters. 2. To assess the adherence to diabetes management practices such as adoption of adequate
physical activity, healthy dietary habits, drug compliance and quitting addiction habits.
|